Panax notoginseng saponins are extracted from Chinese ginseng-Panax notoginseng Ledeb-and are known to have therapeutic anti-inflammatory effects. However, the precise mechanism behind their anti-inflammatory effects remains relatively unknown. To better understand how Panax notoginseng saponins exert their therapeutic benefit, we tested them in a rat model of severe acute pancreatitis (SAP). Rats received a tail vein injection of Panax notoginseng saponins and were administered 5% sodium taurocholate 2 h later. Pancreatic tissue was then harvested and levels of miR-181b, FSTL1, TREM1, TLR4, TRAF6, IRAK1, p-Akt, p-p38MAPK, NF-κBp65, and p-IκB-α were determined using Western blot and quantitative real-time polymerase chain reaction (qRT-PCR). Enzyme-linked immunosorbent assays were used to determine serum levels of tumor necrosis factor-α (TNF-α), TREM1, interleukin (IL)-6, ACAM-1, IL-8, and IL-12 and DNA-bound levels of NF-KB65 and TLR4 in pancreatic and ileum tissue. Serum levels of lipase and amylase, pancreatic myeloperoxidase (MPO) activity, and pancreatic water content were also measured. Hematoxylin and eosin staining was used for all histological analyses. Results indicated upregulation of miR-181b, but negligible levels of FSTL1, p-p38MAPK, TLR4, TRAF6, p-Akt, IRAK1, TREM1, p-NF-κBp65, and p-IκB-α, as well as negligible DNAbound levels of NF-KB65 and TLR4. We also observed lower levels of IL-8, IL-6, ACAM-1, TNF-α, MPO, and IL-12 in the Panax notoginseng saponin-treated group when compared with controls. In addition, Panax notoginseng saponintreated rats had significantly reduced serum levels of lipase and amylase. Histological analyses confirmed that Panax notoginseng saponin treatment significantly reduced taurocholate-induced pancreatic inflammation. Collectively, our results suggest that Panax notoginseng saponin treatment attenuated acute pancreatitis and pancreatic inflammation by increasing miR-181b signaling. These findings suggest that Panax notoginseng saponins have therapeutic potential in the treatment of taurocholate-induced SAP.
Introduction
Severe acute pancreatitis (SAP) is a condition with many complications, resulting in a high death rate of between 20% and 30%. [1] [2] [3] [4] [5] However, acute pancreatitis (AP) is usually mild, has no complications, and usually heals on its own. 1 SAP has several significant pathological features, including a large area of necrotic tissue and extensive pancreatic hemorrhage. 2 Clinically, SAP is often accompanied by acute renal insufficiency, acute lung injury (ALI), and hepatic impairment. 3, 4 Latestage SAP features multiple organ dysfunction syndromes (MODS) , and uncontrolled SAP can result in multiple organ failure (MOF). 3 Despite its significant health effects and high mortality rate, there remains no satisfactory treatment for SAP. Current therapeutic methods are purely symptomatic and focused on pain relief, gastric decompression, and the maintenance of balanced electrolytes, fluids, and pH. 6 Given this great therapeutic need, attention has recently turned to the active ingredients found in Panax notoginseng. 7 It has been hoped that of these, one might prove beneficial in the treatment of SAP.
Panax notoginseng is one of the most commonly used species in traditional Chinese medicines (TCMs) and has significant efficacy in treating pathological hemostasis, promoting blood circulation, and alleviating pain. 7, 8 Panax notoginseng saponins are obtained from Panax notoginseng (Chinese ginseng) extracts and are primarily composed of ginsenosides (Rg1, Rb1, and Rg2), notoginsenoside R1, and RK3. 7 Ginsenoside Rb1 is an inhibitor of vascular cell adhesion molecule 1 (VCAM-1). 8 Several of these compounds have active biological properties; for instance, protopanaxadiol-type saponin is the most potent saponin fraction against tumor necrosis factor-α (TNF-α)-induced monocyte adhesion. 9 Moreover, ginsenoside Rb1 functions as a phytoestrogen and ginsenoside Rg1 has been shown to lower hepatic oxidative stress in exercising rats. 10, 11 In addition, ginsenoside Rg1 protects against memory impairments. 12 Panax notoginseng is also an inhibitor of TNF-α-induced endothelial adhesion molecule expression and monocyte adhesion. 13 In apolipoprotein E (ApoE)-deficient mice, ginsenoside Rg2 also suppresses RAGE/MAPK signaling and helps block nuclear factor kappa B (NF-κB). 14 Finally, Rg1 and RK3 activate the phosphatidylinositol-3 kinase Akt pathway and inhibits p38 MAPK signaling. 8, 15 Critically, Panax notoginseng saponins may be help slow or prevent inflammatory diseases; however, the mechanism(s) of action of Panax notoginseng with regard to disease modification remain relatively unknown.
MicroRNAs (miRNAs) are the primary regulators in a variety of biological processes. 16 Specific disease-related miRNAs that have been recently identified include those for several kinds of cancers, autoimmune diseases, and infectious diseases. [16] [17] [18] Additional related miRNA studies have verified some of these functions in vivo. [19] [20] [21] However, the role of miRNAs in inflammatory diseases like AP remains poorly understood. Relatedly, it is also necessary to better understand whether miR-181b functions as a cytokine-responsive miRNA in the regulation of the pancreatic response to inflammation.
Previous in vivo reports have shown that the FSTL1 protein significantly reduced pro-inflammatory mediator expression in the ischemic areas of the myocardium. 22 Additional in vitro work has extended these findings, showing that the treatment of either cultured cardiomyocytes or macrophages with FSTL1 protein decreased pro-inflammatory gene expression in response to lipopolysaccharide (LPS) application. 23 The first identified member of the TREM family, TREM1, is widely expressed on pathogenexposed myeloid cells. 24 Enhanced TREM1 expression promotes excessive inflammation and increases circulating chemokines and cytokines.
Here, we sought to evaluate the role of the miR181b signaling pathway in taurocholate-induced AP. After taurocholate treatment, miR-181b signaling decreased, FSTL1 and TREM1 signaling pathways were enhanced, and the levels of inflammatory gene and protein levels in the mouse pancreas were elevated. Collectively, these effects contributed to later pancreatic injury. Importantly, Panax notoginseng saponins enhanced miR-181b signaling, blocked FSTL1 and TREM1 activity, and reduced pancreatic injury. This led to a weaker presentation of AP. Taken together, our results demonstrate that Panax notoginseng saponins attenuated AP and pancreatic inflammation by increasing miR-181b signaling activity. Our study further suggests that the miR181b signaling pathway functions as a protective factor in the development of AP.
Materials and methods

Reagents
A commercially available reverse transcription (RT) reaction kit (Takara Shuzo Co., Ltd., Kyoto, Japan) and a commercially available Trizol kit (Invitrogen, Carlsbad, CA, USA) were both used according to the manufacturer's instructions. Commercially available DNA markers and polymerase chain reaction (PCR) kit (Roche, South San Francisco, CA, USA) were also used according to the manufacturer's instructions. Rabbit polyclonal antibodies to FSTL1 and TREM1 were purchased from Sigma Chemical (St. Louis, MO, USA). Rabbit polyclonal anti-Akt, anti-p-Akt, and rabbit polyclonal anti-TLR4 antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA), while rabbit polyclonal antibodies to TRAF6 and IRAK1 were purchased from American Diagnostica (Stamford, CT, USA). Rabbit polyclonal antibodies to p38MAPK and p-p38MAPK were purchased from Cell Signaling Technology). Rabbit polyclonal antibody to p-IRAK1 was purchased from Sigma Chemical, while rabbit polyclonal antibodies toNF-kBp65 and p-NF-kBp65 were obtained from Innovative Research (Southfield, MI, USA). Rabbit polyclonal antibodies to IκB-a and p-IκB-a were purchased from Abcam (Cambridge, MA, USA). Rabbit polyclonal β-actin was obtained from Promega (Madison, WI, USA). ACAM-1 and IL-12 enzyme-linked immune sorbent assay (ELISA) kits were obtained from BioLegend (San Diego, CA, USA), while TNF-α, interleukin (IL)-6, and IL-8 ELISA kits were obtained from the Science and Technology Development Center of the People's Liberation Army General Hospital (Beijing, China).
Drugs
Panax notoginseng saponin extracts were acquired from Yunnan Baiyao Group Co., Ltd. (Kunming, Yunnan, China, Approval No. Zhunzi Z5302149). All active compounds were identified and biochemical fingerprints obtained according to previously reported methods. [7] [8] [9] [10] [11] [12] [13] The main active components included notoginsenoside R1 and ginsenosides Rg1 and Rb1.
Cell culture
The pancreatic acinar cell line 25 was used to observe the in vitro effects of miR-181b on AP. Pancreatic acinar cells were freshly harvested from male Sprague Dawley rats (200-220 g) through enzymatic digestion using a previously described protocol. 26 The harvested pancreatic acinar cells were grown in DMEM containing 100 U/mL penicillin, 5% fetal bovine serum (FBS), 50 µg/L amphotericin B, and 100 U/mL streptomycin at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were cultured in six-well plates until they were subconfluent.
miRNA mimics, miRNA, inhibitors, and gene transfection
Pancreatic acinar cells were cultured to 40% confluence. miR-181b mimics, miR-181b mimic-negative control (NC), miR-181b inhibitor, and miR-181b inhibitor-NC (Invitrogen) were individually added to Lipofectamine 2000 (Invitrogen) and the resulting mixture was added to the cell medium. Total RNA and all proteins were obtained 24 h post-transfection and stored for later quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot analyses.
miR-181b target gene prediction and dual luciferase reporter assay
Two software applications (PicTar, www.pictar.org and Target Scan, http://www.targetscan.org) and one database (www.mirbase.org) were used to determine possible miR-181b targets. Pancreatic acinar cells (1 × 10 5 ) were cultured in 24-well plates and transfected using Lipofectamine 2000 (Invitrogen) with one of the following: FSTL1, TREM1-3′UTR-wt, FSTL1, TREM1-3′ UTR-mt, mi-181b, or mi-NC. At 24 h post-transfection, a luciferase activity was conducted using the Dual Luciferase Reporter Assay System (Promega). Results were then normalized to Renilla luciferase activity.
AdCMV-miR-181b administration
AdCMV-miR-181b was constructed as previously described. 27 A constitutively active miR-181b construct was administered (1 × 10 9 pfu of AdCMVmiR-181b) via tail intravenous injection into Sprague Dawley rats. Administration was followed by taurocholate-induced pancreatitis after 10 days post-intravenous (IV) administration of AdCMVmiR-181b. Control rats received an empty adenoviral vector and identical taurocholate exposure.
Animals
Adult male Sprague Dawley rats were obtained from Kunming Medical University Laboratory Animal Center (Kunming, China). All rats were housed in the Animal Care Facility of Kunming Medical University under pathogen-free conditions in controlled (30%-70%) humidity. Standard laboratory chow and water were provided ad libitum. In all experiments, 8-to 9-week-old rats were used. All experiments were approved by the Animal Care Committee of Kunming Medical University.
Taurocholate-induced SAP
Under aseptic conditions, rats were anesthetized using 1% pentobarbital sodium (i.p., 35 mg/kg body weight). SAP was modeled using a microinfusion pump containing 5% sodium taurocholate (1.5 mL/kg body weight). Taurocholate was administered at a rate of 0.2 mL/min according to previous reports. 28 Sham-operated animals underwent the same surgical procedures but did not have active infusion into the pancreas.
Animal groups and treatment
Rats (n = 32) were equally and randomly divided into the following four groups: sham-operated (SO), sham-operated with treatment (treatment SO), SAP model (model), and SAP model with treatment (treatment SAP). Treatment groups (treatment SO and treatment SAP) received a tail injection (50 mg/kg) of Panax notoginseng saponin extract every 8 h for 24 h. Normal control, sham, and control groups were given the same volume of saline according to the same injection schedule. After 24 h, all rats were anesthetized using 2.5% sodium pentobarbital (150 mg/kg; Wuhan Dinghui Chemical Co., Ltd., Wuhan, China) and the right internal carotid artery was isolated. Blood (5 mL) was extracted and then immediately centrifuged. The supernatant was collected, aliquoted into two sterile tubes, and stored at −20°C until later analysis. Ascites volume was acquired from the opened abdominal wall. Both serum and ascites fluid were used to establish amylase levels and ascitic capacity. After rapid cervical dislocation, ileum and pancreatic tissue were rapidly removed and fixed in 10% formalin for later histological analyses. Separate pancreatic portions were processed to assess water content.
qRT-PCR
Total RNA was extracted using TRIzol (Invitrogen) and a Nanodrop spectrophotometer (ND-100; Thermo, Waltham, MA, USA) used to assess resulting RNA concentrations. Total RNA was reverse transcribed to complementary DNA (cDNA) using the HiScript 1st Strand cDNA Synthesis Kit (Vazyme, Nanjing, China) according to the manufacturer's instructions. The stem-loop RT-qPCR method was used to generate cDNA from miRNAs. 18 All qRT-PCR experiments were performed in triplicate using the ABI StepOnePlus TM real-time PCR system (Applied Biosystems, Foster City, CA, USA). The thermocycling program used was as follows: pre-incubation at 95°C for 10 min, 35 cycles of denaturation at 95°C for 15 s, annealing at 60°C for 5 s, and elongation at 72°C for 12 s. Endogenous controls were U6 and β-actin and were used to generate miRNA and messenger RNA (mRNA) expression profiles, respectively. All expression levels were normalized to their respective endogenous control, and the 2 −∆∆Ct method 20 was used to calculate fold-change in gene expression. Primers are provided in Table 1 .
Western blot analysis
Nuclear, cytoplasmic, and whole protein concentrations obtained from rat pancreatic tissue were determined using the bicinchoninic acid (BCA) method, 22 after which all proteins were run on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE; Bio-Rad, Hercules, CA, USA) using an 80-µg protein aliquot or equal amount of concentrated supernatant, 100 V was used, and for 100 min. The proteins were separated using 4-12% gradient SDS-PAGE and transferred onto polyvinylidene difluoride membranes, 17 mA was used and for overnight. Membranes were blocked with 5% (w/v) milk in TBST (0.05% Tween) at room temperature under agitation for 1 h to prevent non-specific binding. Blots were then incubated overnight at 4°C with primary antibodies including anti-FSTL1 (1:1000), anti-TREM1 (1:1000), anti-Beclin1 (1:200), anti-Akt (1:1000), anti-phospho-Akt (1:1000), anti-TLR4 (1:200), anti-TRAF6 (1:500), anti-IRAK1 (1:500), antiphospho-IRAK1 (1:500), anti-phospho-p38MAPK (1:1000), anti-p38MAPK (1:1000), anti-NF-kBp65 (1:1000), anti-phospho-NF-kBp65 (1:1000), anti-IκB-a (1:1000), anti-phospho-IκB-a (1:1000), and anti-β-actin (1:1000) diluted in 5% bovine serum albumin (BSA). Lamin-A and β-actin were used as the internal references for nuclear/cytoplasmic and whole proteins, respectively. After overnight incubation, membranes were washed with TBST and incubated for 1 h at room temperature with the appropriate secondary goat anti-rabbit IgGhorseradish peroxidase (HRP) antibody (Santa Cruz Biotechnology, Dallas, TX, USA; 1:2000) or goat anti-mouse IgG-HRP antibody (Santa Cruz Biotechnology; 1:2000). All secondary antibodies were diluted in 5% (w/v) milk in TBST. The same protein load was confirmed with β-actin. All Western blots were densitometrically quantified using the Bio-Rad Universal Hood and Quantity One software (Bio-Rad). All results were normalized to β-actin levels in each lane.
Immunohistochemical analysis
Pancreatic tissue sections were subjected to antigen retrieval with Retrievagen A (Zymed Laboratories, Inc., San Francisco, CA, USA) and endogenous peroxidase activity quenched with 3% H 2 O 2 (Tianjin Jinqiang Chemical Co. Ltd., Tianjin, China). Sections were then blocked in 2% BSA in phosphate buffered saline (PBS) to prevent nonspecific binding and incubated with primary anti-NF-κB antibody (1:200; BD Pharmingen, Woburn, MA, USA) for 1 h at room temperature. Sections were then washed with PBS and incubated with a biotinylated rabbit anti-goat antibody (Thermo, Freemont, CA, USA) for 30 min at 37°C. Sections were developed using Vectastain ABC and 3,3′-diaminobenzidine (Sigma-Aldrich, St. Louis, MO, USA). Sections were mounted and analyzed: Five fields (magnification, 200×) were randomly selected from each section and the average proportion of NF-κB-positive cells were counted using a true color, multi-functional cell image analysis management system (Image-Pro Plus; Media Cybernetics Inc., Rockville, MD, USA). All results were expressed as positive units (pu).
Myeloperoxidase activity
Pancreatic neutrophil sequestration was quantified by assessing its myeloperoxidase (MPO) activity. 29 Briefly, pancreatic tissue samples were homogenized in 20 mM phosphate buffer (pH 7.4) and centrifuged for 10 min (12,000g, 4°C). The pellet was re-suspended in 50 mM phosphate buffer (pH 6) with 0.5% hexadecyltrimethylammonium bromide. The suspensions underwent three cycles of freezing and thawing, sonicated for 60 s, and 
Serum amylase, lipase, TREM1, and pro-inflammatory cytokine levels and levels of DNA-bound NF-KB65 and TLR4 in the pancreas and ileum
Serum activities of amylase and lipase were determined using commercially available kits and in conjunction with a Roche/Hitachi modular analytics system (Roche, Mannheim, Germany). A commercial ELISA kit (Quantikine; R&D Systems, Minneapolis, MN, USA) was used to determine the serum levels of TNF-α, IL-8, ACAM-1, IL-6, IL-12, and TREM1 according to the manufacturer's instructions. Levels of DNA-bound NF-KB65 and TLR4 in pancreas and ileum tissue were also assessed using separate, commercially available ELISA kits according to the manufacturer's instructions.
Serum endotoxin and d-lactate assays
Previously collected blood samples were added in ethylenediaminetetraacetic acid (EDTA)-containing tubes, centrifuged, and the serum isolated. Serum samples were stored at −80°C until later assays. Serum endotoxin levels were determined using a quantitative chromogenic endpoint Limulus Amebocyte Lysate (LAL) QCL-1000 kit (Lonza, Walkersville, MD, USA) according to the manufacturer's instructions. Serum d-lactate levels were spectrophotometrically determined using commercially available kits (Genmed, Shanghai, China) according to the manufacturer's instructions.
Pancreatic water content
Pancreata were weighed to assess changes in pancreatic interstitial edema. To determine pancreatic water content, a fresh pancreas sample was blotted, weighed, dried for 12 h at 95°C, and then weighed again. The difference in weight between wet and dry pancreas was calculated as the tissue wet weight percentage.
Histological examination and scoring of the pancreas
Pancreata were fixed overnight in 10% buffered formalin at 4°C and embedded in paraffin. Full-length (4 μm) sections were acquired and stained with hematoxylin and eosin (H&E) for later histological evaluation. According to previously published methods, 30 edema, hemorrhage, inflammation, and necrosis were graded from 0 to 4 as shown in Table 2 .
Histopathological assessment of ileal tissue
After blood sample collection, ileal tissue samples were harvested for later evaluation of any histopathological changes. Briefly, sections were stained with H&E and then examined under light microscopy and blind conditions by two pathologists. Both pathologists assessed ileal histopathology according to the standard scale established by Chiu et al. 31 The degree of mucosal damage was graded as follows: 0 = normal mucosa, 1 = development of subepithelial space at the tip of the villus, 2 = extension of the space with epithelial lifting, 3 = massive epithelial lifting, 4 = denuded villi, and 5 = disintegration of the lamina propria. 
Statistical analyses
All statistical analyses were performed in SPSS 11.0 software (SPSS, Inc., Chicago, IL, USA). Data were expressed as mean ± SD from several independent experiments, as specified in the figure legends. Statistical comparisons between the treatment and control groups were evaluated using a t-test. Linear correlational analyses determined the relationship between two variables. Cochran's Q test with corresponding analysis of variance (ANOVA) was used to perform multiple comparisons (when greater than three groups). P < 0.05 was used to determine statistical significance.
Results
miR-181b significantly downregulated the p38MAPK/NF-κB signaling pathway in pancreatic acinar cells
We first sought to understand the effects of miR181b on the p38MAPK/NF-κB signaling pathway in pancreatic acinar cells. To do this, miR-181b mimic, miR-181b inhibitor, miR-181b mimic-NC, and miR181b inhibitor-NC were individually mixed with Lipofectamine 2000 (Invitrogen) to transfect pancreatic acinar cells. At 24 h post-transfection, qRT-PCR was used to measure miR-181b levels and Western blot was used to measure NF-κBp65, p-p38MAPK, and p-IκB-α levels. Results showed that the miR181b mimic significantly increased miR-181b levels, while the miR-181b inhibitor significantly decreased miR-181b expression (Figure 1(a) and (b)), This decrease in miR-181b levels led to enhanced expression of NF-κBp65, p-IκB-α, and p-p38MAPK; conversely, increasing miR-181b significantly reduced the expressions of NF-κBp65, p-IκB-α, and p-p38MAPK (Figure 1(c) and (d) ). These findings suggest that miR-181b may play a role in the regulation of p38MAPK/NF-κB proinflammatory signaling pathways.
Overexpression of miR-181b blocked TREM1 and FSTL1 protein levels and ameliorated pancreatic damages in rats with taurocholateinduced SAP
In order to explore the relationship between overexpression of miR-181b and pancreatic damage in rats subjected to taurocholate-induced SAP, an Effect of AdCMV-miR-181b on TREM1 and FSTL1 protein levels. An active miR-181b expression construct (1 × 109 pfu of AdCMV-miR-181b) was delivered to rats by intravenous tail administration, followed by taurocholate-induced pancreatitis administration over 10 days. TREM1 and FSTL1 protein levels were determined using Western blot and qRT-PCR used to determine miR-181b expression levels. (a) qRT-PCR analysis of miR-181b levels in pancreatic tissue from four experimental groups (SO group, miR-181b SO group, SAP group and miR-181b SAP group). (b) Quantitative Western blot analysis of in pancreatic tissue from four experimental groups (SO group, miR-181b SO group, SAP group and miR-181b SAP group). The data are expressed as mean ± SD of three independent experiments. *P < 0.05, **P < 0.01, vs the SO group; # P < 0.05, vs the SAP group.
active miR-181b expression construct (1 × 10 9 pfu of AdCMV-miR-181b) was delivered to rats by tail intravenous administration. After taurocholateinduced pancreatitis was induced over the course of 10 days, pancreatic miR-181b levels were determined using qRT-PCR, while pancreatic TREM1 and FSTL1 protein levels were determined using Western blot. Results indicated that intravenous administration of AdCMV-miR-181b significantly increased miR-181b levels (Figure 2(a) ). This administration also significantly blocked pancreatic TREM1 and FSTL1 protein levels ( Figure  2(b) ). Histopathological examination of the pancreas of taurocholate-treated miR-181b rats revealed the markedly reduced inflammatory cell infiltration, severe edema, and a high degree of destruction of the histoarchitecture of the acini cells when compared with control rats (Figure 3 ).
FSTL1 and TREM1 are direct targets of miR181b
We next sought to determine how miR-181b mediated the AP inflammatory response. We used a wellknown database to predict likely targets of miR-181b and found FSTL1 and TREM1-both of which are also important pro-inflammatory regulators of AP. Analysis revealed that FSTL1 and TREM1 mRNA and protein levels were dramatically reduced after miR-181b overexpression (Figure 4 (a) and (b)). To validate the interaction between miR-181b and these two candidates (FSTL1 and TREM1), we constructed wild-type and mutant FSTL1 and TREM1 for a dual luciferase reporter assay (Figure 4 (c) and (d)). As hypothesized, miR-181b bound to the wildtype FSTL1 and TREM1, rather than the mutants (Figure 4(d) ).
Effects of Panax notoginseng saponins on the expressions of miR-181b, FSTL1, Akt, and TREM1 in SAP pancreas
We next sought to determine the pancreatic mRNA and protein levels of miR-181b, FSTL1, TREM1, and Akt in taurocholate-induced SAP. The levels of miR-181 were significantly reduced, while FSTL1, TREM1, and Akt mRNA levels as well as FSTL1, TREM1, and phosphorylated Akt protein levels were significantly upregulated ( Figure 5(a)-(d) ). After the administration of Panax notoginseng saponins, miR-181b expression was significantly increased. Correspondingly, mRNA levels of FSTL1, TREM1, and Akt as well as the protein levels of FSTL1, TREM1, and phosphorylated Akt were all significantly reduced ( Figure 5(a)-(d) ). In sum, Panax notoginseng saponins suppressed mRNA and protein levels of FSTL1, TREM1, and Akt, but upregulated miR-181b expression.
Effects of Panax notoginseng saponins on pancreatic protein levels of TLR4, p-IκB-α, TRAF6, p-IRAK1, p-p38MAPK, and p-NFκBp65 in taurocholate-induced SAP
We next determined the effects of Panax notoginseng saponins on pancreatic protein levels of TLR4, TRAF6, p-p38MAPK, p-IRAK1, p-IκB-α, and p-NF-κBp65 in rats treated with taurocholate using Western blot. In vivo pancreatic protein levels of TLR4, p-IRAK1, TRAF6, p-NF-κBp65, p-p38MAPK, and p-IκB-α were significantly increased in taurocholate-induced SAP group (P < 0.05; Figure 6 ). Interestingly, these levels were significantly reduced after Panax notoginseng saponin administration (P < 0.05; Figure 6 ).
Panax notoginseng saponins inhibited NFκBp65 activity in rat pancreas and ileum tissues with taurocholate-induced SAP
To explore the effects of Panax notoginseng saponins on NF-κBp65 activation in taurocholateinduced SAP, pancreatic and ileal tissue sections were subjected to immunohistochemical staining. NF-κBp65 expression was weak in both the SO and treatment SO groups (Figure 7(a)-(d) ). However, NF-κBp65 expression was significantly increased (P < 0.05) in the taurocholate-induced AP group. However, 24 h after Panax notoginseng saponin administration, NF-κBp65 activity in the pancreas and ileum of taurocholate-induced SAP rats was blocked (P < 0.05; Figure 7 (a)-(d)).
Panax notoginseng saponins inhibited pancreatic and ileal DNA-bound NF-KB65 and TLR4 in taurocholate-induced SAP
To analyze the effects of Panax notoginseng saponins on DNA-bound NF-KB65 and TLR4 in Figure 3 . Effect of AdCMV-miR-181b on pancreatic damage. An active miR-181b expression construct (1 × 109 pfu of AdCMVmiR-181b) was delivered to rats by intravenous tail administration, followed by taurocholate-induced pancreatitis administration over 10 days. (a) Representative images of H&E-stained pancreatic sections from three experimental groups (magnification, 400×).
(b) Pancreatic damage score. The data are expressed as mean ± SD of three independent experiments. *P < 0.05, **P < 0.01, vs the SO group and the miR-181b SO group; # P < 0.05, vs the SAP group.
taurocholate-induced SAP, nuclear protein from tissue sections of the pancreas and ileum were isolated using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce, Waltham, MA, USA). DNA-bound NF-KB65 and TLR4 were then measured using ELISA. DNA-bound NF-KB65 and TLR4 were markedly decreased in the SO group (Figure 7 (e)-(h)). However, DNAbound NF-KB65 and TLR4 were significantly increased (P < 0.05) in the taurocholate-induced AP group. Notably, 24 h after Panax notoginseng saponin administration, DNA-bound NF-KB65 and TLR4 in the pancreas and ileum of taurocholate-induced SAP rats were attenuated (P < 0.05; Figure 7 (e)-(h)).
Effects of Panax notoginseng saponins on MPO activity in the pancreata of rats with taurocholate-induced SAP
After taurocholate induction of SAP, pancreatic MPO activity was significantly increased. However, administration of Panax notoginseng saponins resulted in a significant reduction in MPO activity (Figure 8(b) ).
Effects of Panax notoginseng saponins on serum levels of TREM1, TNF-α, ICAM-1, IL-6, and IL-12
Serum levels of the pro-inflammatory cytokines (TNF-α, ICAM-1, IL-6, and IL-12) and proinflammatory protein (TREM1) were significantly increased in taurocholate-induced SAP rats. However, administration of Panax notoginseng saponins resulted in significant reductions in the levels of TREM1, TNF-α, ICAM-1, IL-6, and IL-12 ( Figure 8(a) , (c)-(f)).
Effects of Panax notoginseng saponins on the ratio of the pancreas to body weight, ascites, and serum amylase activity in taurocholateinduced SAP rats
Pancreatic edema is a major assessment criterion of pancreatitis; given this, we sought to determine if there was any difference after treatment with Panax notoginseng saponins. After 5% sodium taurocholate was injected into the biliary-pancreatic duct of rats, the ratios of the pancreas to body weight and ascites were significantly increased (Figure 9(a)-(c) ). In addition, serum amylase was significantly increased in SAP rats. However, Panax notoginseng saponin treatment significantly reduced serum amylase activity. It also significantly reduced ascites and the ratio of the pancreas to body weight, indicating a beneficial effect of Panax notoginseng saponins on pancreatic edema and injury (Figure 9(a)-(c) ).
Effects of Panax notoginseng saponins on serum endotoxin and d-lactate in taurocholate-induced SAP rats
Serum levels of endotoxin, d-lactate, and TREM1 were also measured to analyze the effects of Panax notoginseng saponins in SAP rats. Serum endotoxin and d-lactate levels were significantly increased 24 h after the administration of 5% sodium taurocholate (Figure 9(d) and (e)). However, Panax notoginseng saponin treatment significantly reduced serum levels of both endotoxin and d-lactate. , p-NF-κBp65, p-p38MAPK, and P-IκB-α. The data are expressed as mean ± SD of three independent experiments. **P < 0.01, vs the SO group and the treatment SO group; # P < 0.05, vs the SAP group.
Effects of Panax notoginseng saponins on pancreatic and ileal histology in taurocholate-induced SAP rats
In order to evaluate the effects of Panax notoginseng saponins on local pancreatic and ileal injury, we next examined pancreatic and ileal morphology. The SAP group showed a high degree of destruction of the histoarchitecture of acini cells, severe edema, and significantly higher pancreatic pathological scores than those in either the SO or treatment SO groups (Figure 9 (f)-(h)). After SAP induction of SAP, villi and crypt structures were also partially damaged; in particular, hair became thinner and shorter. We also observed heavy inflammatory cell infiltration in the intrinsic membrane as well as lymphatic dilatation and edema (Figure 9 (h) and (i)). In the Panax notoginseng saponin treatment group, injuries to the pancreatic and ileal tissues were alleviated, with significant reductions in pancreatic and ileal injury scores (Figure 9(f)-(i) ).
Discussion
The initial and subsequent rapid deterioration in SAP may be caused by the overexpression of pro-inflammatory cytokines, which are believed to be critical to the pathogenesis of the disease. 1 In particular, cytokines from macrophages are considered to play an integral role in the development of AP. 3 In this study, taurocholate-induced SAP led to increased levels of TNF-α, ACAM-1, IL-6, IL-12, and IL-8; critically, Panax notoginseng saponin treatment significantly reduced levels of TNF-α, ACAM-1, IL-6, IL-12, and IL-8. These results were consistent with our pancreatic MPO activity analysis, indicating neutrophil and macrophage diapedesis 32 in the pancreas. Panax notoginseng saponins successfully attenuated pancreas' MPO activity, blocked tissue neutrophilia, and ameliorated taurocholate-induced pancreatic injury.
To explore the effects of miR-181b on SAP, we measured miR-181b expression in rat pancreatic tissue. Pancreatic miR-181b levels were significantly downregulated in pancreatic tissue samples from rats with SAP. Moreover, the level of downregulation was associated with an exacerbated pancreatitis response and worse pancreatic injury. However, miR-181b overexpression attenuated the pancreatitis response and ameliorated pancreatic injury, highlighting the key role miRNAs play as post-transcriptional regulators of biological processes. 17, 18, 33 Key inflammatory regulators are related to the homeostatic response to inflammatory stimuli by activating the TLR4 pathway 34 and various TLR-mediated immune responses to bacterial infection by either suppressing the inflammatory response or reducing inflammatory triggers. 35 The miR-181 family may control inflammation under pathological conditions, thus affecting growth, activation, and development. 36 The results presented here were consistent with previous work. 37 To this end, there is evidence that miR181a, miR-181b, and miR-181d function as regulators of TLR/NF-κB signaling as their expression is significantly decreased in the monocytes of obese patients. Correspondingly, their levels were increased and restored to the normal levels in lean subjects who had lost weight. 38 Moreover, type 2 diabetes patients administered resveratrol-enriched grape extracts for 1 year had decreased expression of pro-inflammatory cytokines-including CCL3, TNF-α, and IL-1β-in peripheral blood mononuclear cells. This was also associated with increased expression of six miRNAs, including miR-181b. 39 Thus, the correlation results combined with the known role of miR-181b in reducing downstream NF-κB signaling 37 suggest that miR-181b plays a protective role in inflammatory diseases. Emerging evidence strongly indicates a role for TREM1 in non-infectious inflammatory disorders. 40 TREM1 possesses the ability to amplify signaling in either a TLR4-or TLR2-dependent manner. 41 In particular, the co-stimulation of neutrophils or monocytes with the TLR4 ligand and endotoxin LPS results in a synergistic increase in pro-inflammatory cytokine expression. 41, 42 Our study found that TREM1 was the direct target of miR-181b. The decrease in miR-181b by taurocholate-induced AP significantly increased TREM1 levels. This significant increase was correlated with increased activities of TLR4 and the p38 MAPK signaling pathway, as well as worse taurocholate-induced pancreatic injury. Our study also found that this increase in TREM1 level was inhibited by upregulation of miR-181b after Panax notoginseng saponin administration. This inhibitory effect was correlated with the reduced activities of TLR4 and the p38 MAPK signaling pathway, as well as improved taurocholate-induced pancreatic damage.
Our results clearly showed that Panax notoginseng saponins inhibited the IRAK1/TRAF6 signaling pathway and reduced pancreatic inflammation. Specifically, IRAK1 is an adaptor for the Toll/IL-1R receptor signaling complex. 43 IRAK4 may also phosphorylate IRAK1 to initiate its autophosphorylation. Hyperphosphorylated IRAK1 dissociates from the complex, dimerizes, and is bound to TNF receptor-associated factor 6 (TRAF6). IRAK1 binds to TRAF6 with Ubc13/Uev1A to catalyze the Lys63-mediated polyubiquitination of IRAK1. IRAK1 results in the polyubiquitination and dimerization of TRAF6 and thus transforming growth factor-β-activated kinase 1 (TAK1). 43 TAK1 phosphorylates a suite of regulatory kinases across various signaling pathways, generating and releasing multiple cytokines via NF-κB activation. 44 Finally, activated NF-κB can translocate to the nucleus and bind to promoters of pro-inflammatory genes, thus enhancing the inflammatory response. 44 NF-κB activation can lead to other signaling pathways, such as TLR and p38MAPK, which have been extensively explored. 44 Inhibitors of p38MAPK (SB203580) can decrease the levels of LPS-induced pro-inflammatory proteins. 45 Here, Panax notoginseng saponins reduced p38 MAPK and NF-κB signaling activity, DNA-bound NF-KB65 and TLR4 in the pancreas and ileum of taurocholate-induced SAP rats, and pancreas and ileum inflammation. Panax notoginseng saponin treatment also attenuated taurocholate-induced pancreatic damage.
FSTL1 significantly promotes the expression of inflammatory cytokines by activating the NF-κB pathway; 46 FSTL1 also activates TLR4 signaling. 47 Here, FSTL1 was shown to be a direct target of miR-181b. Taurocholate-induced AP attenuated the activity of miR-181b, elevated FSTL1 expression, enhanced the activities of TLR4 and MAPK signaling, stimulated the pancreatic inflammatory response, and promoted taurocholate-induced pancreatic damage. Conversely, Panax notoginseng saponins enhanced miR-181b expression, blocked FSTL1 expression, attenuated the pancreatic inflammatory response, and reduced taurocholateinduced pancreatic damage.
The PI3K/Akt pathway was identified as an endogenous feedback mechanism for the activation of pro-inflammatory factors. 48, 49 Accordingly, PI3K/Akt inhibition is known to decrease serum cytokine levels in mice. 50 Previous studies indicated that Akt could phosphorylate and activate IκB kinase IKK-α and cause the degradation of IκB nuclear translocation of NF-κB. Akt has also been shown to promote cytokine expression, including IL-1β, IL-18, and TNF-α, leading to accelerated inflammation. 9 Here, taurocholateinduced acute pancreatitis downregulated miR181b activity, stimulated Akt gene expression and phosphorylated Akt expression, and promoted inflammatory gene and protein expression. Collectively, this led to enhanced pancreatic inflammation. However, Panax notoginseng saponin administration reduced phosphorylated Akt expression by enhancing miR-181b expression, thus attenuating pancreatic inflammation.
Pancreatic edema is one of the main indicators used for assessing pancreatitis. 3 Serum amylase activity is also a common indicator for assessing pancreatitis. 2 This study confirmed that the administration of Panax notoginseng saponins reduced serum amylase activity, attenuated pancreatic edema, and reduced acute pancreatic injury.
AP is often accompanied by intestinal injury. 51 To this end, plasma d-lactic acid is an important indicator to evaluate intestinal mucosal barrier damage. 51 Our data showed that SAP increased serum d-lactic acid levels, confirming the presence of intestinal mucosal barrier damage. This mucosal barrier damage increased intestinal permeability, enhanced serum endotoxin levels, increased pancreatic and intestinal inflammation, and led to more severe SAP. However, in our study, we found that the administration of Panax notoginseng saponins ameliorated mucosal barrier damage, blocked intestinal permeability, reduced serum endotoxin levels, attenuated pancreatic and intestinal inflammation, and ameliorated SAP.
Panax notoginseng saponins exert a protective effect against SAP induced by taurocholate. This therapeutic effect is mediated through miR-181b upregulation and inhibition of TREM1, FSTL1, TLR4, NF-κB, and p38 MAPK pathways. This results in reduced pancreatic and intestinal inflammation, ameliorated mucosal barrier damage, decreased serum endotoxin levels, and attenuated taurocholateinduced pancreatic damage. Collectively, our results suggest the potential use of Panax notoginseng saponins in the treatment of inflammatory diseases such as AP, sepsis, and MODS. 
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